Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 4 clinical trials
A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry Disease (CARAT)

alfa, agalsidase beta, or migalastat) to evaluate the effect of venglustat on left ventricular mass index (LVMI) in adult participants with Fabry disease and left ventricular hypertrophy.

ventricular hypertrophy
agalsidase alfa
hypertrophy
migalastat
agalsidase beta
  • 0 views
  • 17 May, 2022
  • 1 location
A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry Disease (CARAT)

alfa, agalsidase beta, or migalastat) to evaluate the effect of venglustat on left ventricular mass index (LVMI) in adult participants with Fabry disease and left ventricular hypertrophy.

ventricular hypertrophy
agalsidase alfa
hypertrophy
migalastat
agalsidase beta
  • 0 views
  • 20 May, 2022
  • 3 locations
Fabry Disease Registry & Pregnancy Sub-registry

(such as enzyme replacement therapy with agalsidase beta) and irrespective of the commercial product with which she may be treated. Data from the Sub-registry are also used to fulfill various global

fabrazyme
deficiency
replacement therapy
alpha-galactosidase
agalsidase beta
  • 0 views
  • 18 Feb, 2022
  • 252 locations
Fabry Disease Registry & Pregnancy Sub-registry

(such as enzyme replacement therapy with agalsidase beta) and irrespective of the commercial product with which she may be treated. Data from the Sub-registry are also used to fulfill various global

fabrazyme
deficiency
replacement therapy
alpha-galactosidase
agalsidase beta
  • 460 views
  • 24 Mar, 2022
  • 252 locations